Sharing of knowledge and practice improvement at EBMT
The European Group for Blood and Marrow Transplantation (EBMT) held its 44th Annual Meeting in 2018, with delegates once again expressing the multitude of reasons that they attend each year. Speaking ...
Author: VJHemOnc
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Veno-occlusive disease e-learning for nurses
Veno-occlusive disease (VOD) is a serious complication that can occur following stem cell transplantation, for which the appropriate management is essential. Here, John Murray, RGN, MSc, President of ...
Author: VJHemOnc
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
The EBMT NG awards: recognizing and sharing the work of nurses
The European Group for Blood and Marrow Transplantation Nurses Group (EBMT NG), founded in 1985, is a well-established coalition that aims to promote excellence in the delivery of transplantation and ...
Author: VJHemOnc
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
EBMT and the EBMT Nurses Group: improving patient care
The European Group for Blood and Marrow Transplantation (EBMT) is committed to developing and advancing the care of patients. In this interview, Jacqui Stringer, PhD, BSc, RGN, MIFPA, Chairperson of t...
Author: VJHemOnc
Added: 03/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2018 Category: Cancer & Oncology Source Type: podcasts
ADD - Best options for early relapse after undergoing VRd therapy with stem cell transplant?
In this video, Dr. Brian G.M. Durie explains that second transplant and certain novel therapies may work well for early relapse of myeloma.<br /><br />BOTTOM LINE:<br />Many options are available in cases of earl...
Author: InternationalMyelomaFoundation
Added: 03/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody
To date, stem cell transplantation has been the best curative treatment method for acute leukemia, for which T-cells are the faciliatators of the graft versus leukemia response. As explained here by M...
Author: VJHemOnc
Added: 03/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Using Microbiome Transplantation or FMT for RCC They should still benefit from their given immunotherapy with additional supplements
Aly-Khan Lalani, MD from Dana-Farber Cancer Institute discusses tUsing Microbiome Transplantation or FMT for RCC They should still benefit from their given immunotherapy with additional supplements at...
Author: Genitourinary-Cancer-Meeting
Added: 02/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Strategies for Treating Relapsed Myeloma - Daratumumab with IMiDs, Venetoclax, Transplants
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss different strategies for treatin...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Tandem Transplantation in Multiple Myeloma - Phase 3 Trial showed patients had a progression free survival benefit
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the tandem transplantation in...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
New Agents Becoming Available for the 1st time in Decades - What agents can be safely combined in pre & post transplant therapy
Jonathan Gerber, MD from Levine Cancer Institute discusses new agents becoming available for the 1st time in decades and what agents can be safely combined in pre & post transplant therapy at the 2017...
Author: ASHReport
Added: 01/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2018 Category: Cancer & Oncology Source Type: podcasts
Changed the Strategy of Chemotherapy and Transplants Gentle upfront then the intensive strategy for curative transplant
Jonathan Gerber, MD from Levine Cancer Institute discusses changed the strategy of chemotherapy and transplants and gentle upfront then the intensive strategy for curative transplant at the 2017 Ameri...
Author: ASHReport
Added: 01/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2018 Category: Cancer & Oncology Source Type: podcasts
ONC201 Safety and Advantages
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the ONC201 Safety and Advantages including No Hair Loss, No Mucositis, Stable Blood...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
ONC201 Patient Disqualifiers Parental Metastasis, Esophageal Metastasis and Too Sick to Travel
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the ONC201 Patient Disqualifiers such as Parental Metastasis, Esophageal Metastasis...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
ONC201 Patient Disqualifiers Peritoneal Metastasis, Esophageal Metastasis and Too Sick to Travel
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the ONC201 Patient Disqualifiers such as Peritoneal Metastasis, Esophageal Metastas...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
ONC201 Moving to Phase III Establish Better Quality of Life & amp; Tumor Markers May Lead to Fastrack
Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses moving ONC201 from Phase 2 to Phase 3 and how they need to Establish Better Quality...
Author: Cancer-News
Added: 01/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2018 Category: Cancer & Oncology Source Type: podcasts
